カテゴリー： LP Information, 世界, 部品/材料

世界の医薬品用エラストマー市場予測 2023年-2029年

◆英語タイトル：Global Elastomers for Pharmaceuticals Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU5032）◆商品コード：LP23JU5032
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：115
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の医薬品用エラストマー市場」は、過去の販売実績から2022年の世界の医薬品用エラストマーの総販売量を検討し、2023年から2029年の予測される医薬品用エラストマーの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医薬品用エラストマーの市場規模を掲載し、XXX百万米ドル規模の世界の医薬品用エラストマー市場の詳細な分析を提供します。本インサイトレポートは、世界の医薬品用エラストマー業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の医薬品用エラストマー市場における各社の独自のポジションをより深く理解するために、医薬品用エラストマー製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の医薬品用エラストマー市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医薬品用エラストマーの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医薬品用エラストマーの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医薬品用エラストマーのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

医薬品用エラストマーの世界主要メーカーとしては、Exxon Mobil Corporation、 DuPont、 BASF SE、 Dow、 Kuraray Co. Ltd、 Lubrizol Corp、 Bailey-Parks Urethane Inc、 Covestro、 Arkema Group、 Hexpol Compounding、 Avient Corporation、 Teknor Apex Company、 Austin Novel Materials Co、 Huafon Group、 Miracll Chemicals Ltdなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医薬品用エラストマー市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では医薬品用エラストマー市場をセグメンテーションし、種類別 (熱硬化性エラストマー、熱可塑性エラストマー)、用途別 (ストッパー、注射器、ニードルシールド、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：熱硬化性エラストマー、熱可塑性エラストマー

・用途別区分：ストッパー、注射器、ニードルシールド、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の医薬品用エラストマー市場の10年間の市場状況・展望は？
・世界および地域別に見た医薬品用エラストマー市場成長の要因は何か？
・医薬品用エラストマーの市場機会はエンドマーケットの規模によってどのように変化するのか？
・医薬品用エラストマーのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：医薬品用エラストマーの年間販売量2018-2029、地域別現状・将来分析
・医薬品用エラストマーの種類別セグメント：熱硬化性エラストマー、熱可塑性エラストマー
・医薬品用エラストマーの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・医薬品用エラストマーの用途別セグメント：ストッパー、注射器、ニードルシールド、その他
・医薬品用エラストマーの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の医薬品用エラストマー市場
・企業別のグローバル医薬品用エラストマー市場データ：2018-2023年の年間販売量、市場シェア
・企業別の医薬品用エラストマーの年間売上：2018-2023年の売上、市場シェア
・企業別の医薬品用エラストマー販売価格
・主要企業の医薬品用エラストマー生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

医薬品用エラストマーの地域別レビュー
・地域別の医薬品用エラストマー市場規模2018-2023：年間販売量、売上
・主要国別の医薬品用エラストマー市場規模2018-2023：年間販売量、売上
・南北アメリカの医薬品用エラストマー販売の成長
・アジア太平洋の医薬品用エラストマー販売の成長
・ヨーロッパの医薬品用エラストマー販売の成長
・中東・アフリカの医薬品用エラストマー販売の成長

南北アメリカ市場
・南北アメリカの国別の医薬品用エラストマー販売量、売上（2018-2023）
・南北アメリカの医薬品用エラストマーの種類別販売量
・南北アメリカの医薬品用エラストマーの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の医薬品用エラストマー販売量、売上（2018-2023）
・アジア太平洋の医薬品用エラストマーの種類別販売量
・アジア太平洋の医薬品用エラストマーの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の医薬品用エラストマー販売量、売上（2018-2023）
・ヨーロッパの医薬品用エラストマーの種類別販売量
・ヨーロッパの医薬品用エラストマーの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の医薬品用エラストマー販売量、売上（2018-2023）
・中東・アフリカの医薬品用エラストマーの種類別販売量
・中東・アフリカの医薬品用エラストマーの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・医薬品用エラストマーの製造コスト構造分析
・医薬品用エラストマーの製造プロセス分析
・医薬品用エラストマーの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・医薬品用エラストマーの主要なグローバル販売業者
・医薬品用エラストマーの主要なグローバル顧客

地域別の医薬品用エラストマー市場予測レビュー
・地域別の医薬品用エラストマー市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・医薬品用エラストマーの種類別市場規模予測
・医薬品用エラストマーの用途別市場規模予測

主要企業分析
Exxon Mobil Corporation、 DuPont、 BASF SE、 Dow、 Kuraray Co. Ltd、 Lubrizol Corp、 Bailey-Parks Urethane Inc、 Covestro、 Arkema Group、 Hexpol Compounding、 Avient Corporation、 Teknor Apex Company、 Austin Novel Materials Co、 Huafon Group、 Miracll Chemicals Ltd
・企業情報
・医薬品用エラストマー製品
・医薬品用エラストマー販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Elastomer is defined as a long chain co-polymer or terpolymer (two or three different monomers in one chain) that contains adequate crosslinks among individual chains. Elastomers are polymers that offer excellent properties such as high elasticity as well as viscosity. They offer low permeability to moisture and gas; as well as high temperature resistance.Elastomers help meet the changing requirements of drug compatibility and cleanliness in pharmaceutical, medical and health care industries. They offer several beneficial properties. For instance, they possess low extractability and leachability. Elastomers are super-clean solutions for sensitive drugs and various other pharmaceutical applications such as pharmaceutical stoppers and container closures.
LPI (LP Information)’ newest research report, the “Elastomers for Pharmaceuticals Industry Forecast” looks at past sales and reviews total world Elastomers for Pharmaceuticals sales in 2022, providing a comprehensive analysis by region and market sector of projected Elastomers for Pharmaceuticals sales for 2023 through 2029. With Elastomers for Pharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Elastomers for Pharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global Elastomers for Pharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Elastomers for Pharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Elastomers for Pharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Elastomers for Pharmaceuticals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Elastomers for Pharmaceuticals.
The global Elastomers for Pharmaceuticals market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Elastomers for Pharmaceuticals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Elastomers for Pharmaceuticals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Elastomers for Pharmaceuticals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Elastomers for Pharmaceuticals players cover Exxon Mobil Corporation, DuPont, BASF SE, Dow, Kuraray Co. Ltd, Lubrizol Corp, Bailey-Parks Urethane Inc, Covestro and Arkema Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Elastomers for Pharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Thermoset Elastomers
Thermoplastic Elastomers
Segmentation by application
Stoppers
Syringes
Needle Shields
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Exxon Mobil Corporation
DuPont
BASF SE
Dow
Kuraray Co. Ltd
Lubrizol Corp
Bailey-Parks Urethane Inc
Covestro
Arkema Group
Hexpol Compounding
Avient Corporation
Teknor Apex Company
Austin Novel Materials Co
Huafon Group
Miracll Chemicals Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Elastomers for Pharmaceuticals market?
What factors are driving Elastomers for Pharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Elastomers for Pharmaceuticals market opportunities vary by end market size?
How does Elastomers for Pharmaceuticals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Elastomers for Pharmaceuticals Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Elastomers for Pharmaceuticals by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Elastomers for Pharmaceuticals by Country/Region, 2018, 2022 & 2029
2.2 Elastomers for Pharmaceuticals Segment by Type
2.2.1 Thermoset Elastomers
2.2.2 Thermoplastic Elastomers
2.3 Elastomers for Pharmaceuticals Sales by Type
2.3.1 Global Elastomers for Pharmaceuticals Sales Market Share by Type (2018-2023)
2.3.2 Global Elastomers for Pharmaceuticals Revenue and Market Share by Type (2018-2023)
2.3.3 Global Elastomers for Pharmaceuticals Sale Price by Type (2018-2023)
2.4 Elastomers for Pharmaceuticals Segment by Application
2.4.1 Stoppers
2.4.2 Syringes
2.4.3 Needle Shields
2.4.4 Others
2.5 Elastomers for Pharmaceuticals Sales by Application
2.5.1 Global Elastomers for Pharmaceuticals Sale Market Share by Application (2018-2023)
2.5.2 Global Elastomers for Pharmaceuticals Revenue and Market Share by Application (2018-2023)
2.5.3 Global Elastomers for Pharmaceuticals Sale Price by Application (2018-2023)
3 Global Elastomers for Pharmaceuticals by Company
3.1 Global Elastomers for Pharmaceuticals Breakdown Data by Company
3.1.1 Global Elastomers for Pharmaceuticals Annual Sales by Company (2018-2023)
3.1.2 Global Elastomers for Pharmaceuticals Sales Market Share by Company (2018-2023)
3.2 Global Elastomers for Pharmaceuticals Annual Revenue by Company (2018-2023)
3.2.1 Global Elastomers for Pharmaceuticals Revenue by Company (2018-2023)
3.2.2 Global Elastomers for Pharmaceuticals Revenue Market Share by Company (2018-2023)
3.3 Global Elastomers for Pharmaceuticals Sale Price by Company
3.4 Key Manufacturers Elastomers for Pharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Elastomers for Pharmaceuticals Product Location Distribution
3.4.2 Players Elastomers for Pharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Elastomers for Pharmaceuticals by Geographic Region
4.1 World Historic Elastomers for Pharmaceuticals Market Size by Geographic Region (2018-2023)
4.1.1 Global Elastomers for Pharmaceuticals Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Elastomers for Pharmaceuticals Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Elastomers for Pharmaceuticals Market Size by Country/Region (2018-2023)
4.2.1 Global Elastomers for Pharmaceuticals Annual Sales by Country/Region (2018-2023)
4.2.2 Global Elastomers for Pharmaceuticals Annual Revenue by Country/Region (2018-2023)
4.3 Americas Elastomers for Pharmaceuticals Sales Growth
4.4 APAC Elastomers for Pharmaceuticals Sales Growth
4.5 Europe Elastomers for Pharmaceuticals Sales Growth
4.6 Middle East & Africa Elastomers for Pharmaceuticals Sales Growth
5 Americas
5.1 Americas Elastomers for Pharmaceuticals Sales by Country
5.1.1 Americas Elastomers for Pharmaceuticals Sales by Country (2018-2023)
5.1.2 Americas Elastomers for Pharmaceuticals Revenue by Country (2018-2023)
5.2 Americas Elastomers for Pharmaceuticals Sales by Type
5.3 Americas Elastomers for Pharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Elastomers for Pharmaceuticals Sales by Region
6.1.1 APAC Elastomers for Pharmaceuticals Sales by Region (2018-2023)
6.1.2 APAC Elastomers for Pharmaceuticals Revenue by Region (2018-2023)
6.2 APAC Elastomers for Pharmaceuticals Sales by Type
6.3 APAC Elastomers for Pharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Elastomers for Pharmaceuticals by Country
7.1.1 Europe Elastomers for Pharmaceuticals Sales by Country (2018-2023)
7.1.2 Europe Elastomers for Pharmaceuticals Revenue by Country (2018-2023)
7.2 Europe Elastomers for Pharmaceuticals Sales by Type
7.3 Europe Elastomers for Pharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Elastomers for Pharmaceuticals by Country
8.1.1 Middle East & Africa Elastomers for Pharmaceuticals Sales by Country (2018-2023)
8.1.2 Middle East & Africa Elastomers for Pharmaceuticals Revenue by Country (2018-2023)
8.2 Middle East & Africa Elastomers for Pharmaceuticals Sales by Type
8.3 Middle East & Africa Elastomers for Pharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Elastomers for Pharmaceuticals
10.3 Manufacturing Process Analysis of Elastomers for Pharmaceuticals
10.4 Industry Chain Structure of Elastomers for Pharmaceuticals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Elastomers for Pharmaceuticals Distributors
11.3 Elastomers for Pharmaceuticals Customer
12 World Forecast Review for Elastomers for Pharmaceuticals by Geographic Region
12.1 Global Elastomers for Pharmaceuticals Market Size Forecast by Region
12.1.1 Global Elastomers for Pharmaceuticals Forecast by Region (2024-2029)
12.1.2 Global Elastomers for Pharmaceuticals Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Elastomers for Pharmaceuticals Forecast by Type
12.7 Global Elastomers for Pharmaceuticals Forecast by Application
13 Key Players Analysis
13.1 Exxon Mobil Corporation
13.1.1 Exxon Mobil Corporation Company Information
13.1.2 Exxon Mobil Corporation Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.1.3 Exxon Mobil Corporation Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Exxon Mobil Corporation Main Business Overview
13.1.5 Exxon Mobil Corporation Latest Developments
13.2 DuPont
13.2.1 DuPont Company Information
13.2.2 DuPont Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.2.3 DuPont Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 DuPont Main Business Overview
13.2.5 DuPont Latest Developments
13.3 BASF SE
13.3.1 BASF SE Company Information
13.3.2 BASF SE Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.3.3 BASF SE Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BASF SE Main Business Overview
13.3.5 BASF SE Latest Developments
13.4 Dow
13.4.1 Dow Company Information
13.4.2 Dow Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.4.3 Dow Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dow Main Business Overview
13.4.5 Dow Latest Developments
13.5 Kuraray Co. Ltd
13.5.1 Kuraray Co. Ltd Company Information
13.5.2 Kuraray Co. Ltd Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.5.3 Kuraray Co. Ltd Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Kuraray Co. Ltd Main Business Overview
13.5.5 Kuraray Co. Ltd Latest Developments
13.6 Lubrizol Corp
13.6.1 Lubrizol Corp Company Information
13.6.2 Lubrizol Corp Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.6.3 Lubrizol Corp Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lubrizol Corp Main Business Overview
13.6.5 Lubrizol Corp Latest Developments
13.7 Bailey-Parks Urethane Inc
13.7.1 Bailey-Parks Urethane Inc Company Information
13.7.2 Bailey-Parks Urethane Inc Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.7.3 Bailey-Parks Urethane Inc Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bailey-Parks Urethane Inc Main Business Overview
13.7.5 Bailey-Parks Urethane Inc Latest Developments
13.8 Covestro
13.8.1 Covestro Company Information
13.8.2 Covestro Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.8.3 Covestro Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Covestro Main Business Overview
13.8.5 Covestro Latest Developments
13.9 Arkema Group
13.9.1 Arkema Group Company Information
13.9.2 Arkema Group Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.9.3 Arkema Group Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Arkema Group Main Business Overview
13.9.5 Arkema Group Latest Developments
13.10 Hexpol Compounding
13.10.1 Hexpol Compounding Company Information
13.10.2 Hexpol Compounding Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.10.3 Hexpol Compounding Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hexpol Compounding Main Business Overview
13.10.5 Hexpol Compounding Latest Developments
13.11 Avient Corporation
13.11.1 Avient Corporation Company Information
13.11.2 Avient Corporation Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.11.3 Avient Corporation Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Avient Corporation Main Business Overview
13.11.5 Avient Corporation Latest Developments
13.12 Teknor Apex Company
13.12.1 Teknor Apex Company Company Information
13.12.2 Teknor Apex Company Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.12.3 Teknor Apex Company Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Teknor Apex Company Main Business Overview
13.12.5 Teknor Apex Company Latest Developments
13.13 Austin Novel Materials Co
13.13.1 Austin Novel Materials Co Company Information
13.13.2 Austin Novel Materials Co Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.13.3 Austin Novel Materials Co Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Austin Novel Materials Co Main Business Overview
13.13.5 Austin Novel Materials Co Latest Developments
13.14 Huafon Group
13.14.1 Huafon Group Company Information
13.14.2 Huafon Group Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.14.3 Huafon Group Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Huafon Group Main Business Overview
13.14.5 Huafon Group Latest Developments
13.15 Miracll Chemicals Ltd
13.15.1 Miracll Chemicals Ltd Company Information
13.15.2 Miracll Chemicals Ltd Elastomers for Pharmaceuticals Product Portfolios and Specifications
13.15.3 Miracll Chemicals Ltd Elastomers for Pharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Miracll Chemicals Ltd Main Business Overview
13.15.5 Miracll Chemicals Ltd Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Elastomers for Pharmaceuticals Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Elastomers for Pharmaceuticals Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Thermoset Elastomers
Table 4. Major Players of Thermoplastic Elastomers
Table 5. Global Elastomers for Pharmaceuticals Sales by Type (2018-2023) & (Kiloton)
Table 6. Global Elastomers for Pharmaceuticals Sales Market Share by Type (2018-2023)
Table 7. Global Elastomers for Pharmaceuticals Revenue by Type (2018-2023) & ($ million)
Table 8. Global Elastomers for Pharmaceuticals Revenue Market Share by Type (2018-2023)
Table 9. Global Elastomers for Pharmaceuticals Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Elastomers for Pharmaceuticals Sales by Application (2018-2023) & (Kiloton)
Table 11. Global Elastomers for Pharmaceuticals Sales Market Share by Application (2018-2023)
Table 12. Global Elastomers for Pharmaceuticals Revenue by Application (2018-2023)
Table 13. Global Elastomers for Pharmaceuticals Revenue Market Share by Application (2018-2023)
Table 14. Global Elastomers for Pharmaceuticals Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Elastomers for Pharmaceuticals Sales by Company (2018-2023) & (Kiloton)
Table 16. Global Elastomers for Pharmaceuticals Sales Market Share by Company (2018-2023)
Table 17. Global Elastomers for Pharmaceuticals Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Elastomers for Pharmaceuticals Revenue Market Share by Company (2018-2023)
Table 19. Global Elastomers for Pharmaceuticals Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Elastomers for Pharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Elastomers for Pharmaceuticals Products Offered
Table 22. Elastomers for Pharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Elastomers for Pharmaceuticals Sales by Geographic Region (2018-2023) & (Kiloton)
Table 26. Global Elastomers for Pharmaceuticals Sales Market Share Geographic Region (2018-2023)
Table 27. Global Elastomers for Pharmaceuticals Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Elastomers for Pharmaceuticals Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Elastomers for Pharmaceuticals Sales by Country/Region (2018-2023) & (Kiloton)
Table 30. Global Elastomers for Pharmaceuticals Sales Market Share by Country/Region (2018-2023)
Table 31. Global Elastomers for Pharmaceuticals Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Elastomers for Pharmaceuticals Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Elastomers for Pharmaceuticals Sales by Country (2018-2023) & (Kiloton)
Table 34. Americas Elastomers for Pharmaceuticals Sales Market Share by Country (2018-2023)
Table 35. Americas Elastomers for Pharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Elastomers for Pharmaceuticals Revenue Market Share by Country (2018-2023)
Table 37. Americas Elastomers for Pharmaceuticals Sales by Type (2018-2023) & (Kiloton)
Table 38. Americas Elastomers for Pharmaceuticals Sales by Application (2018-2023) & (Kiloton)
Table 39. APAC Elastomers for Pharmaceuticals Sales by Region (2018-2023) & (Kiloton)
Table 40. APAC Elastomers for Pharmaceuticals Sales Market Share by Region (2018-2023)
Table 41. APAC Elastomers for Pharmaceuticals Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Elastomers for Pharmaceuticals Revenue Market Share by Region (2018-2023)
Table 43. APAC Elastomers for Pharmaceuticals Sales by Type (2018-2023) & (Kiloton)
Table 44. APAC Elastomers for Pharmaceuticals Sales by Application (2018-2023) & (Kiloton)
Table 45. Europe Elastomers for Pharmaceuticals Sales by Country (2018-2023) & (Kiloton)
Table 46. Europe Elastomers for Pharmaceuticals Sales Market Share by Country (2018-2023)
Table 47. Europe Elastomers for Pharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Elastomers for Pharmaceuticals Revenue Market Share by Country (2018-2023)
Table 49. Europe Elastomers for Pharmaceuticals Sales by Type (2018-2023) & (Kiloton)
Table 50. Europe Elastomers for Pharmaceuticals Sales by Application (2018-2023) & (Kiloton)
Table 51. Middle East & Africa Elastomers for Pharmaceuticals Sales by Country (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Elastomers for Pharmaceuticals Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Elastomers for Pharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Elastomers for Pharmaceuticals Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Elastomers for Pharmaceuticals Sales by Type (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Elastomers for Pharmaceuticals Sales by Application (2018-2023) & (Kiloton)
Table 57. Key Market Drivers & Growth Opportunities of Elastomers for Pharmaceuticals
Table 58. Key Market Challenges & Risks of Elastomers for Pharmaceuticals
Table 59. Key Industry Trends of Elastomers for Pharmaceuticals
Table 60. Elastomers for Pharmaceuticals Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Elastomers for Pharmaceuticals Distributors List
Table 63. Elastomers for Pharmaceuticals Customer List
Table 64. Global Elastomers for Pharmaceuticals Sales Forecast by Region (2024-2029) & (Kiloton)
Table 65. Global Elastomers for Pharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Elastomers for Pharmaceuticals Sales Forecast by Country (2024-2029) & (Kiloton)
Table 67. Americas Elastomers for Pharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Elastomers for Pharmaceuticals Sales Forecast by Region (2024-2029) & (Kiloton)
Table 69. APAC Elastomers for Pharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Elastomers for Pharmaceuticals Sales Forecast by Country (2024-2029) & (Kiloton)
Table 71. Europe Elastomers for Pharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Elastomers for Pharmaceuticals Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Middle East & Africa Elastomers for Pharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Elastomers for Pharmaceuticals Sales Forecast by Type (2024-2029) & (Kiloton)
Table 75. Global Elastomers for Pharmaceuticals Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Elastomers for Pharmaceuticals Sales Forecast by Application (2024-2029) & (Kiloton)
Table 77. Global Elastomers for Pharmaceuticals Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Exxon Mobil Corporation Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. Exxon Mobil Corporation Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 80. Exxon Mobil Corporation Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Exxon Mobil Corporation Main Business
Table 82. Exxon Mobil Corporation Latest Developments
Table 83. DuPont Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. DuPont Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 85. DuPont Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. DuPont Main Business
Table 87. DuPont Latest Developments
Table 88. BASF SE Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. BASF SE Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 90. BASF SE Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. BASF SE Main Business
Table 92. BASF SE Latest Developments
Table 93. Dow Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Dow Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 95. Dow Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Dow Main Business
Table 97. Dow Latest Developments
Table 98. Kuraray Co. Ltd Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Kuraray Co. Ltd Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 100. Kuraray Co. Ltd Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Kuraray Co. Ltd Main Business
Table 102. Kuraray Co. Ltd Latest Developments
Table 103. Lubrizol Corp Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Lubrizol Corp Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 105. Lubrizol Corp Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Lubrizol Corp Main Business
Table 107. Lubrizol Corp Latest Developments
Table 108. Bailey-Parks Urethane Inc Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Bailey-Parks Urethane Inc Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 110. Bailey-Parks Urethane Inc Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Bailey-Parks Urethane Inc Main Business
Table 112. Bailey-Parks Urethane Inc Latest Developments
Table 113. Covestro Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. Covestro Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 115. Covestro Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Covestro Main Business
Table 117. Covestro Latest Developments
Table 118. Arkema Group Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. Arkema Group Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 120. Arkema Group Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Arkema Group Main Business
Table 122. Arkema Group Latest Developments
Table 123. Hexpol Compounding Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Hexpol Compounding Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 125. Hexpol Compounding Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Hexpol Compounding Main Business
Table 127. Hexpol Compounding Latest Developments
Table 128. Avient Corporation Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 129. Avient Corporation Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 130. Avient Corporation Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Avient Corporation Main Business
Table 132. Avient Corporation Latest Developments
Table 133. Teknor Apex Company Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 134. Teknor Apex Company Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 135. Teknor Apex Company Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Teknor Apex Company Main Business
Table 137. Teknor Apex Company Latest Developments
Table 138. Austin Novel Materials Co Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 139. Austin Novel Materials Co Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 140. Austin Novel Materials Co Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Austin Novel Materials Co Main Business
Table 142. Austin Novel Materials Co Latest Developments
Table 143. Huafon Group Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 144. Huafon Group Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 145. Huafon Group Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Huafon Group Main Business
Table 147. Huafon Group Latest Developments
Table 148. Miracll Chemicals Ltd Basic Information, Elastomers for Pharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 149. Miracll Chemicals Ltd Elastomers for Pharmaceuticals Product Portfolios and Specifications
Table 150. Miracll Chemicals Ltd Elastomers for Pharmaceuticals Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. Miracll Chemicals Ltd Main Business
Table 152. Miracll Chemicals Ltd Latest Developments
List of Figures
Figure 1. Picture of Elastomers for Pharmaceuticals
Figure 2. Elastomers for Pharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Elastomers for Pharmaceuticals Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Elastomers for Pharmaceuticals Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Elastomers for Pharmaceuticals Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Thermoset Elastomers
Figure 10. Product Picture of Thermoplastic Elastomers
Figure 11. Global Elastomers for Pharmaceuticals Sales Market Share by Type in 2022
Figure 12. Global Elastomers for Pharmaceuticals Revenue Market Share by Type (2018-2023)
Figure 13. Elastomers for Pharmaceuticals Consumed in Stoppers
Figure 14. Global Elastomers for Pharmaceuticals Market: Stoppers (2018-2023) & (Kiloton)
Figure 15. Elastomers for Pharmaceuticals Consumed in Syringes
Figure 16. Global Elastomers for Pharmaceuticals Market: Syringes (2018-2023) & (Kiloton)
Figure 17. Elastomers for Pharmaceuticals Consumed in Needle Shields
Figure 18. Global Elastomers for Pharmaceuticals Market: Needle Shields (2018-2023) & (Kiloton)
Figure 19. Elastomers for Pharmaceuticals Consumed in Others
Figure 20. Global Elastomers for Pharmaceuticals Market: Others (2018-2023) & (Kiloton)
Figure 21. Global Elastomers for Pharmaceuticals Sales Market Share by Application (2022)
Figure 22. Global Elastomers for Pharmaceuticals Revenue Market Share by Application in 2022
Figure 23. Elastomers for Pharmaceuticals Sales Market by Company in 2022 (Kiloton)
Figure 24. Global Elastomers for Pharmaceuticals Sales Market Share by Company in 2022
Figure 25. Elastomers for Pharmaceuticals Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Elastomers for Pharmaceuticals Revenue Market Share by Company in 2022
Figure 27. Global Elastomers for Pharmaceuticals Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Elastomers for Pharmaceuticals Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Elastomers for Pharmaceuticals Sales 2018-2023 (Kiloton)
Figure 30. Americas Elastomers for Pharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 31. APAC Elastomers for Pharmaceuticals Sales 2018-2023 (Kiloton)
Figure 32. APAC Elastomers for Pharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 33. Europe Elastomers for Pharmaceuticals Sales 2018-2023 (Kiloton)
Figure 34. Europe Elastomers for Pharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Elastomers for Pharmaceuticals Sales 2018-2023 (Kiloton)
Figure 36. Middle East & Africa Elastomers for Pharmaceuticals Revenue 2018-2023 ($ Millions)
Figure 37. Americas Elastomers for Pharmaceuticals Sales Market Share by Country in 2022
Figure 38. Americas Elastomers for Pharmaceuticals Revenue Market Share by Country in 2022
Figure 39. Americas Elastomers for Pharmaceuticals Sales Market Share by Type (2018-2023)
Figure 40. Americas Elastomers for Pharmaceuticals Sales Market Share by Application (2018-2023)
Figure 41. United States Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Elastomers for Pharmaceuticals Sales Market Share by Region in 2022
Figure 46. APAC Elastomers for Pharmaceuticals Revenue Market Share by Regions in 2022
Figure 47. APAC Elastomers for Pharmaceuticals Sales Market Share by Type (2018-2023)
Figure 48. APAC Elastomers for Pharmaceuticals Sales Market Share by Application (2018-2023)
Figure 49. China Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Elastomers for Pharmaceuticals Sales Market Share by Country in 2022
Figure 57. Europe Elastomers for Pharmaceuticals Revenue Market Share by Country in 2022
Figure 58. Europe Elastomers for Pharmaceuticals Sales Market Share by Type (2018-2023)
Figure 59. Europe Elastomers for Pharmaceuticals Sales Market Share by Application (2018-2023)
Figure 60. Germany Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Elastomers for Pharmaceuticals Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Elastomers for Pharmaceuticals Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Elastomers for Pharmaceuticals Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Elastomers for Pharmaceuticals Sales Market Share by Application (2018-2023)
Figure 69. Egypt Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Elastomers for Pharmaceuticals Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Elastomers for Pharmaceuticals in 2022
Figure 75. Manufacturing Process Analysis of Elastomers for Pharmaceuticals
Figure 76. Industry Chain Structure of Elastomers for Pharmaceuticals
Figure 77. Channels of Distribution
Figure 78. Global Elastomers for Pharmaceuticals Sales Market Forecast by Region (2024-2029)
Figure 79. Global Elastomers for Pharmaceuticals Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Elastomers for Pharmaceuticals Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Elastomers for Pharmaceuticals Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Elastomers for Pharmaceuticals Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Elastomers for Pharmaceuticals Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の医薬品用エラストマー市場予測 2023年-2029年(Global Elastomers for Pharmaceuticals Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のパフォーマンスエラストマー市場予測 2023年-2029年
  • 世界の航空宇宙・防衛用エラストマー市場予測 2023年-2029年
  • 世界のイソプレンゴムラテックス（IRL）市場予測 2023年-2029年
  • 世界の液状合成ゴム（LSR）市場予測 2023年-2029年
  • 世界のEPDM（エチレンプロピレンジエンモノマー）市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆